Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ADVANCED NON-SMALL CELL LUNG CANCER, . Treffer: 4

2018

Buder, A; Hochmair, MJ; Schwab, S; Bundalo, T; Schenk, P; Errhalt, P; Mikes, RE; Absenger, G; Patocka, K; Baumgartner, B; Setinek, U; Burghuber, OC; Prosch, H; Pirker, R; Filipits, M Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
J THORAC ONCOL. 2018; 13(6): 821-830. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Pircher, A; Manzl, C; Fiegl, M; Popper, H; Pirker, R; Hilbe, W Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient.
Lung Cancer. 2014; 83(3): 408-410. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2011

Watzka, SB; Posch, F; Hochmair, M; Setinek, U; Köstler, WJ; Müller, MR Resistance to EGFR targeting therapies in lung cancer.
Minerva Chir. 2011; 66(5): 483-494.
Web of Science PubMed

 

2006

Pohl, G; Krajnik, G; Malayeri, R; Müller, RM; Klepetko, W; Eckersberger, F; Schäfer-Prokop, C; Pokrajac, B; Schmeikal, S; Maier, A; Ambrosch, G; Woltsche, M; Minar, W; Pirker, R Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer.
Lung Cancer. 2006; 54(1):63-67
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum